Get started
Author

TC Spelsberg

Capillary electrophoresis: a powerful microanalytical technique for biologically active molecules.
1993 · J P Landers, R P Oda, et al. · PubMed · 85
Dose-response of estrogen on bone versus the uterus in ovariectomized mice
2004 · UI Modder, BL Riggs, et al. · European Journal of Endocrinology · 84
Endoxifen, but not 4-hydroxytamoxifen, degrades the estrogen receptor in breast cancer cells: a differential mechanism of action potentially explaining CYP2D6 effect.
2009 · JR Hawse, X Wu, et al. · Cancer Research · 8
Mechanisms of estrogen action on bone.
1989 · B L Riggs, T C Spelsberg · PubMed · 3
Isolation of the Epstein-Barr virus nuclear antigen from chromatin preparations.
1978 · G M Pikler, G R Pearson, et al. · PubMed · 3
Abstract PD05-11: Development, Characterization, and Effective In Vitro Treatment of an Endoxifen Resistant Breast Cancer Cell Line
2010 · JR Hawse, M Subramaniam, et al. · Cancer Research · 1
[Characterization of nuclear acceptor sites for the progesterone receptor of the chick oviduct (author's transl)].
1982 · H Toyoda, T C Spelsberg · PubMed · 1
Abstract P6-04-03: ERb and breast cancer: A potential predictive and prognostic biomarker and novel therapeutic drug target
2013 · JR Hawse, M Subramaniam, et al. · Cancer Research
Abstract P5-05-01: Endoxifen, a novel breast cancer therapy, elicits unique beneficial effects on bone relative to that of other selective estrogen receptor modulators
2013 · JR Hawse, A Gingery, et al. · Cancer Research
P3-16-09: Endoxifen, a Newly Developed Breast Cancer Drug, Has Anabolic Actions on the Mouse Skeleton.
2011 · JR Hawse, M Cicek, et al. · Cancer Research
P4-02-03: Biological Functions of Estrogen Receptor-beta and Its Variants in Breast Cancer.
2011 · JR Hawse, X Wu, et al. · Cancer Research
Abstract P2-09-25: ERα Expression in Breast Cancer: A Conundrum of Antibody Specificity?
2010 · X Wu, M Subramaniam, et al. · Cancer Research
Works count: 12
Citation count: 185
H-index: 3
I10-index: 2
Year
Topic
Type